Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ahad Ahmed Kodipad"'
Autor:
Valentina Griggio, Candida Vitale, Maria Todaro, Chiara Riganti, Joanna Kopecka, Chiara Salvetti, Riccardo Bomben, Michele Dal Bo, Daniela Magliulo, Davide Rossi, Gabriele Pozzato, Lisa Bonello, Monia Marchetti, Paola Omedè, Ahad Ahmed Kodipad, Luca Laurenti, Giovanni Del Poeta, Francesca Romana Mauro, Rosa Bernardi, Thorsten Zenz, Valter Gattei, Gianluca Gaidano, Robin Foà, Massimo Massaia, Mario Boccadoro, Marta Coscia
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
In chronic lymphocytic leukemia (CLL), the hypoxia-inducible factor 1 (HIF-1) regulates the response of tumor cells to hypoxia and their protective interactions with the leukemic microenvironment. In this study, we demonstrate that CLL cells from TP5
Externí odkaz:
https://doaj.org/article/32e74ba222404eab81c81c9599841830
Autor:
Rabinarayan Parhi, Ahad Ahmed Kodipad, Suvendu Kumar Sahoo, Ravi Kumar, Priyadharshini Selvaraj, Kondapuram Parameshwar
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:997-1005
The prime objective behind this investigation was to plan a Letrozole enclosed adhesive transdermal patch; since the transdermal route is an outright attractive option concerning its route, convenience and safety. Letrozole, a non-steroidal type II a
Autor:
Abdurraouf Mokhtar Mahmoud, Gianluca Gaidano, Ramesh Adhinaveni, Riccardo Moia, Sruthi Sagiraju, Andrea Patriarca, Ahad Ahmed Kodipad, Paola Boggione
Publikováno v:
Expert Opinion on Therapeutic Targets. 24:1239-1250
Genomic studies have allowed to identify molecular predictors for chronic lymphocytic leukemia (CLL) treatment tailoring.The review covers the p53 biological pathway, its genetic alterations and clinical implications in CLL, and its druggable targets
Autor:
Michael Alexander, Amish Asthana, Justine M. Aziz, Appakalai N. Balamurugan, Rita Bottino, Lori Nicole Byers, Antonio Citro, Peter J. Cowan, Kimia Damyar, Robert A. Fisher, Peter J. Friend, Adam Good, Paul A. Grisales, Wayne J. Hawthorne, Aaron Hui, David Imagawa, Amy C. Kelly, Jong-Min Kim, Ahad Ahmed Kodipad, Jonathan R.T. Lakey, Thomas Loudovaris, Colleen Luong, Sri Prakash L. Mokshagundam, Siddharth Narayanan, Jaimie D. Nathan, Ann Etohan Ogbemudia, Gabriel Oniscu, Giuseppe Orlando, Klearchos K. Papas, Chung-Gyu Park, Andrea Peloso, Lev T. Perelman, Giuseppe Pettinato, Henry Pleass, Horacio Rilo, Krishna Kumar Samaga, John R. Savino, Thomas M. Suszynski, Andrew I. Sutherland, Alicia Wells, David Whaley, Ivana Xu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d6f27beff56a6d02c9d8c08ae586736
https://doi.org/10.1016/b978-0-12-824011-3.09990-2
https://doi.org/10.1016/b978-0-12-824011-3.09990-2
Autor:
Appakalai N. Balamurugan, Krishna Kumar Samaga, Siddharth Narayanan, Ahad Ahmed Kodipad, Sri Prakash L. Mokshagundam, Jaimie D. Nathan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ceb6cf382cacac5126510376afe985f
https://doi.org/10.1016/b978-0-12-824011-3.00008-4
https://doi.org/10.1016/b978-0-12-824011-3.00008-4
Autor:
Mattia Schipani, Chiara Favini, Riccardo Moia, Clara Deambrogi, Andrea Patriarca, Ahad Ahmed Kodipad, Gianluca Gaidano, Silvia Rasi
Publikováno v:
Expert review of hematology. 13(2)
Introduction: During the past few years, new genomic approaches have elucidated the molecular genetics of chronic lymphocytic leukemia (CLL) to a large extent. As a consequence, specific hi...
Autor:
Francesco Zaja, Giovanni D'Arena, Antonella Zucchetto, Stefano Baldoni, Adalgisa Condoluci, Lydia Scarfò, Annalisa Chiarenza, Ramesh Adhinaveni, Jacopo Olivieri, Andrea Patriarca, Valeria Spina, Alessio Bruscaggin, Sruthi Sagiraju, Lorenzo De Paoli, Tamara Bittolo, Ahad Ahmed Kodipad, Lodovico Terzi di Bergamo, Gianluca Gaidano, Giovanni Del Poeta, Valter Gattei, Silvia Rasi, Silvia Bonfiglio, Clara Deambrogi, Roberto Marasca, Valentina Ferri, Rossana Maffei, Gloria Margiotta Casaluci, Riccardo Bomben, Abdurraouf Mokhtar Mahmoud, Paolo Sportoletti, Chiara Favini, Ilaria Del Giudice, Katia Mokabari, Riccardo Moia, Sara Raponi, Davide Rossi, Paolo Ghia, Francesca Rossi, Robin Foà
Publikováno v:
Blood. 136:31-32
Background. Approximately 70% of newly diagnosed chronic lymphocytic leukemia (CLL) patients present in early Binet or Rai stage, may never require treatment, and may have a life expectancy similar to that of the general population. Two independent a
Autor:
Riccardo Moia, Chiara Favini, Silvia Rasi, Ramesh Adhinaveni, Mattia Schipani, Sruthi Sagiraju, Andrea Patriarca, Ahad Ahmed Kodipad, Abdurraouf Mokhtar Mahmoud, Valentina Ferri, Gianluca Gaidano, Clara Deambrogi, Luca Nassi
Publikováno v:
Journal of Cancer Metastasis and Treatment. 2019
Autor:
Riccardo Bomben, Paola Omedè, Marta Coscia, Robin Foà, Michele Dal Bo, Mario Boccadoro, Davide Rossi, Gabriele Pozzato, Daniela Magliulo, Giovanni Del Poeta, Valentina Griggio, Rosa Bernardi, Chiara Riganti, Francesca Romana Mauro, Maria Todaro, Gianluca Gaidano, Chiara Salvetti, Massimo Massaia, Joanna Kopecka, Lisa Bonello, Luca Laurenti, Candida Vitale, Thorsten Zenz, Valter Gattei, Monia Marchetti, Ahad Ahmed Kodipad
Publikováno v:
Haematologica
In chronic lymphocytic leukemia (CLL), the hypoxia-inducible factor 1 (HIF-1) regulates the response of tumor cells to hypoxia and their protective interactions with the leukemic microenvironment. In this study, we demonstrate that CLL cells from TP5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb31a4be5ed06525bf909946aab5894d
http://hdl.handle.net/2108/241221
http://hdl.handle.net/2108/241221
Autor:
Francesca Romana Mauro, Sruthi Sagiraju, Davide Rossi, Giovanni Del Poeta, Denise Peroni, Silvia Rasi, Ken I. Mills, Gian Matteo Rigolin, Sarah Lawless, Riccardo Bomben, Ilaria Del Giudice, Annalisa Chiarenza, Robin Foà, Francesca Arruga, Fary Diop, Alessio Bruscaggin, Marina Motta, Luca Laurenti, Marta Coscia, Ramesh Adhinaveni, Lorenzo De Paoli, Patrick Thornton, Phil Weir, Chiara Favini, Simone Favini, Riccardo Moia, Roberto Marasca, Carlo Visco, Antonio Cuneo, Omar Perbellini, Antonia Follenzi, Lodovico Terzi-di-Bergamo, Francesca Rossi, Renzo Boldorini, Andrea Patriarca, Alessandra Tedeschi, Clara Deambrogi, Ahad Ahmed Kodipad, Elisa Spaccarotella, Mark Catherwood, Chiara Tarantelli, Clive Jabangwe, Valeria Spina, Francesco Forconi, Francesco Bertoni, Francesco Zaja, David Donaldson, Valter Gattei, Gianluca Gaidano, Agostino Cortelezzi, Silvia Deaglio
Publikováno v:
Davide Rossi 2019, ' Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia ', HAEMATOLOGICA . https://doi.org/10.3324/haematol.2019.219550
Haematologica
Haematologica
BIRC3 is a recurrently mutated gene in chronic lymphocytic leukemia (CLL) but the functional implications of BIRC3 mutations are largely unexplored. Furthermore, little is known about the prognostic impact of BIRC3 mutations in CLL cohorts homogeneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952333991fed5f97826df1310377582b
http://hdl.handle.net/2318/1711581
http://hdl.handle.net/2318/1711581